Follow
Antti Haapalinna
Antti Haapalinna
Vice President R&D,Head of External Research and Partnering
Verified email at orionpharma.com
Title
Cited by
Cited by
Year
Adrenergic α2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice
J Sallinen, A Haapalinna, T Viitamaa, BK Kobilka, M Scheinin
Journal of Neuroscience 18 (8), 3035-3042, 1998
2511998
Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia
J Kuhmonen, J Pokorny, R Miettinen, A Haapalinna, J Jolkkonen, ...
The Journal of the American Society of Anesthesiologists 87 (2), 371-377, 1997
2161997
Genetic alteration of α2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective α2 …
J Sallinen, RE Link, A Haapalinna, T Viitamaa, M Kulatunga, B Sjöholm, ...
Molecular pharmacology 51 (1), 36-46, 1997
2161997
Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia
J Jolkkonen, K Puurunen, J Koistinaho, R Kauppinen, A Haapalinna, ...
European journal of pharmacology 372 (1), 31-36, 1999
1791999
Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
J Sallinen, A Haapalinna, E MacDonald, T Viitamaa, J Lähdesmäki, ...
Molecular psychiatry 4 (5), 443-452, 1999
1411999
Behavioral effects of the α2-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats
J Jolkkonen, K Puurunen, S Rantakömi, A Härkönen, A Haapalinna, ...
European journal of pharmacology 400 (2-3), 211-219, 2000
1382000
Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α2‐Adrenoceptor Antagonist
A Pertovaara, A Haapalinna, J Sirviö, R Virtanen
CNS drug reviews 11 (3), 273-288, 2005
1372005
Evaluation of the α2C-adrenoceptor as a neuropsychiatric drug target: studies in transgenic mouse models
M Scheinin, J Sallinen, A Haapalinna
Life sciences 68 (19-20), 2277-2285, 2001
1322001
An α2-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats
K Puurunen, J Jolkkonen, J Sirviö, A Haapalinna, J Sivenius
Neuropharmacology 40 (4), 597-606, 2001
1292001
Pharmacological characterization and CNS effects of a novel highly selective α2C‐adrenoceptor antagonist JP‐1302
J Sallinen, I Höglund, M Engström, J Lehtimäki, R Virtanen, J Sirviö, ...
British journal of pharmacology 150 (4), 391-402, 2007
1112007
Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1-and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison …
A Haapalinna, T Viitamaa, E MacDonald, JM Savola, L Tuomisto, ...
Naunyn-Schmiedeberg's archives of pharmacology 356, 570-582, 1997
991997
Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat
J Kuhmonen, A Haapalinna, J Sivenius
Journal of neural transmission 108, 261-271, 2001
892001
D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype
J Sallinen, A Haapalinna, T Viitamaa, BK Kobilka, M Scheinin
Neuroscience 86 (3), 959-965, 1998
891998
Catechol 0-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats
R Liljequist, A Haapalinna, M Ahlander, YH Li, PT Männistö
Behavioural brain research 82 (2), 195-202, 1997
811997
Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats
K Puurunen, J Jolkkonen, J Sirviö, A Haapalinna, J Sivenius
Experimental neurology 167 (2), 348-355, 2001
712001
Stimulation of alpha-1 adrenergic receptors facilitates spatial learning in rats
T Puumala, S Greijus, K Narinen, A Haapalinna, P Riekkinen Sr, J Sirviö
European neuropsychopharmacology 8 (1), 17-26, 1998
641998
α‐Adrenoceptor‐Mediated Modulation of 5‐HT2 Receptor Agonist Induced Impulsive Responding in a 5‐Choice Serial Reaction Time Task
T Koskinen, A Haapalinna, J Sirvi
Pharmacology & toxicology 92 (5), 214-225, 2003
612003
α2-Adrenergic control of dopamine overflow and metabolism in mouse striatum
L Yavich, R Lappalainen, J Sirviö, A Haapalinna, E MacDonald
European journal of pharmacology 339 (2-3), 113-119, 1997
601997
Atipamezole, an α2-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats
A Pitkänen, S Narkilahti, Z Bezvenyuk, A Haapalinna, J Nissinen
Epilepsy research 61 (1-3), 119-140, 2004
592004
Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks
S Ruotsalainen, A Haapalinna, PJ Riekkinen SR, J Sirviö
Pharmacology Biochemistry and Behavior 56 (1), 31-40, 1997
581997
The system can't perform the operation now. Try again later.
Articles 1–20